Publications
- Commentary: Circulation tumor cells as a prognastic marker of hormonal resistance prostate carcinoma2009 | First Faculty of Medicine
- Circulating tumor cells as a prognostic and prediction biomarker in female patients with breast carcinomaPublication without faculty affiliation
- Prevention, diagnosis and treatment of cancer-associated thromboembolism2023 | First Faculty of Medicine, Faculty of Medicine in Hradec Králové, Faculty of Medicine in Pilsen
- Karcinom prsu - výzvy pro rok 20232023 | First Faculty of Medicine
- Standing ovations jsou zasloužené2023 | First Faculty of Medicine
- Therapeutic options in patients with early breast cancer2023 | First Faculty of Medicine
- A přesto je palbociklib užitečný lék2023 | First Faculty of Medicine
- Neoadjuvant treatment of HER2-positive breast cance2023 | First Faculty of Medicine
- Trastuzumab deruxtecan as standard of care for second-line treatment of metastatic HER2-positive breast cancer2023 | First Faculty of Medicine
- Konjugáty protilátky a léčiva v léčbě HER2 pozitivního a HER2 low karcinomu prsu2023 | First Faculty of Medicine
Loading network view...